{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:45:46Z","timestamp":1789238746740,"version":"build-2803163510"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Edinburgh Clinical Academic Track (ECAT)\/Wellcome Trust PhD Training Fellowship for Clinicians","award":["214178\/Z\/18\/Z"],"award-info":[{"award-number":["214178\/Z\/18\/Z"]}]},{"name":"Edinburgh Clinical Academic Track (ECAT)\/Wellcome Trust PhD Training Fellowship for Clinicians","award":["R01-AI165671"],"award-info":[{"award-number":["R01-AI165671"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We systematically evaluated randomized-controlled trials (RCTs) for Staphylococcus aureus bacteremia (SAB). There was intertrial heterogeneity in cohort characteristics, including bacteremia source, complicated SAB, and comorbidities. Reporting of cohort characteristics was itself variable, including bacteremia source and illness severity. Selection bias was introduced by exclusion criteria relating to comorbidities, illness severity, infection types, and source control. Mortality was lower in RCT control arms compared with observational cohorts. Differences in outcome definitions impedes meta-analysis. These issues complicate the interpretation and application of SAB RCT results. The value of these trials should be maximized by a standardized approach to recruitment, definitions, and reporting.<\/jats:p>","DOI":"10.1093\/infdis\/jiac219","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T19:34:20Z","timestamp":1654025660000},"page":"723-728","source":"Crossref","is-referenced-by-count":21,"title":["Heterogeneity in <i>Staphylococcus aureus<\/i> Bacteraemia Clinical Trials Complicates Interpretation of Findings"],"prefix":"10.1093","volume":"226","author":[{"given":"Heather W","family":"Dolby","sequence":"first","affiliation":[{"name":"University of Edinburgh Centre for Inflammation Research, Queen\u2019s Medical Research Institute , Edinburgh , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A","family":"Clifford","sequence":"additional","affiliation":[{"name":"Regional Infectious Diseases Unit, Western General Hospital , Edinburgh , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian F","family":"Laurenson","sequence":"additional","affiliation":[{"name":"Clinical Microbiology, Royal Infirmary of Edinburgh , Edinburgh , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Vance G","family":"Fowler","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and International Health, Department of Medicine, Duke University School of Medicine , Durham, North Carolina , USA"},{"name":"Duke Clinical Research Institute , Durham, North Carolina , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9873-8243","authenticated-orcid":false,"given":"Clark D","family":"Russell","sequence":"additional","affiliation":[{"name":"University of Edinburgh Centre for Inflammation Research, Queen\u2019s Medical Research Institute , Edinburgh , United Kingdom"},{"name":"Regional Infectious Diseases Unit, Western General Hospital , Edinburgh , United Kingdom"},{"name":"Clinical Microbiology, Royal Infirmary of Edinburgh , Edinburgh , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"key":"2022090418285250700_jiac219-B1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"2022090418285250700_jiac219-B2","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/cid\/ciy774","article-title":"Considerations for clinical trials of Staphylococcus aureus bloodstream infection in adults","volume":"68","author":"Holland","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022090418285250700_jiac219-B3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.coisb.2017.04.003","article-title":"Treatable traits and therapeutic targets: goals for systems biology in infectious disease","volume":"2","author":"Russell","year":"2017","journal-title":"Curr Opin Syst Biol"},{"key":"2022090418285250700_jiac219-B4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(18)30177-2","article-title":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial","volume":"6","author":"Calfee","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2022090418285250700_jiac219-B5","doi-asserted-by":"publisher","DOI":"10.1101\/2020.09.02.279349","article-title":"Graphia: a platform for the graph-based visualisation and analysis of complex data [preprint]","author":"Freeman","year":"2020","journal-title":"bioRxiv"},{"key":"2022090418285250700_jiac219-B6","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v077.i01","article-title":"ranger: a fast implementation of random forests for high dimensional data in C++ and R","author":"Wright","year":"2017","journal-title":"J Stat Softw"},{"key":"2022090418285250700_jiac219-B7","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.297.11.1233","article-title":"Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review","volume":"297","author":"Van Spall","year":"2007","journal-title":"JAMA"},{"key":"2022090418285250700_jiac219-B8","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/377540","article-title":"Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci","volume":"37","author":"Kim","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2022090418285250700_jiac219-B9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1469-0691.2005.01359.x","article-title":"Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre","volume":"12","author":"Kaech","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"2022090418285250700_jiac219-B10","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0140-6736(17)32456-X","article-title":"Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Thwaites","year":"2018","journal-title":"Lancet"},{"key":"2022090418285250700_jiac219-B11","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/cid\/ciz112","article-title":"Changing characteristics of Staphylococcus aureus bacteremia: results from a 21-year, prospective, longitudinal study","volume":"69","author":"Souli","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022090418285250700_jiac219-B12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac177","article-title":"How generalizable are randomized controlled trials (RCTs) in Staphylococcus aureus bacteremia? A description of the mortality gap between RCTs and observational studies","author":"Bai","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2022090418285250700_jiac219-B13","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.17.20155218","article-title":"ISARIC COVID-19 clinical data report issued: 27 March 2022 [preprint]","author":"Group","year":"2022","journal-title":"medRxiv"},{"key":"2022090418285250700_jiac219-B14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1473-3099(13)70327-X","article-title":"Open source clinical science for emerging infections","volume":"14","author":"Dunning","year":"2014","journal-title":"Lancet Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiac219\/44035669\/jiac219.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/226\/4\/723\/45689106\/jiac219.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/226\/4\/723\/45689106\/jiac219.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T18:29:45Z","timestamp":1662316185000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/226\/4\/723\/6593971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":14,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,5,27]]},"published-print":{"date-parts":[[2022,9,4]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiac219","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8,15]]},"published":{"date-parts":[[2022,5,27]]}}}